Pompano Beach, Fla., Nov. 24, 2015 (GLOBE NEWSWIRE) -- DS Healthcare Group today announced that world-renowned Physician, Dermatologist, and Scientist Dr. Antonella Tosti has joined the DS Laboratories team as esteemed Medical Advisor. Dr. Tosti is an Italian physician and scientist responsible for groundbreaking contributions in the field of dermatology.
As a founding member and past president of The European Hair Research Society and current member of the board of directors of the North American Research Society, Dr. Tosti is recognized globally as a leading authority and expert in hair disorders. Dr. Tosti has authored over 650 scientific publications, 6 academic textbooks on hair disorders and numerous dermatological monographs. Her research, insights and clinical advances on hair disorders over 4 decades have led to industry-changing evolutions. Considered by many to be the foremost expert on hair disorders, thinning, and scalp/skin issues it is no surprise that clients wait many months for an appointment at Dr. Tosti’s eponymous clinic in Bologna, Italy.
“I am very happy to be collaborating with DS Laboratories’ fine team to design and develop more of the most effective products for hair growth and care in the world,” said Dr. Tosti from the World Hair Research Congress in Miami on Friday. Addressing an audience of top scientists from private industries and academics from over 100 universities including Yale, Johns Hopkins, NYU, and Columbia, Dr. Tosti demonstrated her long-established authority as the industry’s most ardent supporter of commercial and consumer advancements through scientific progress. Exhibiting alongside Dr. Tosti at the WHCR, DS Laboratories’ premium personal care products received overwhelmingly positive responses from the crowds.
“We are very fortunate to be innovating with someone of the caliber of Dr. Tosti. The natural alignment of our corporate strategy combined with Dr. Tosti’s lifelong commitment to science-based treatments confirms DS Laboratories’ unwavering mission to bridge technology and research with personal care for our customers worldwide,” said Renee Barch-Niles, CEO of DS Healthcare Group. “This partnership exemplifies our company’s dedication to making scientifically proven, cutting-edge, superior personal care products that make a meaningful difference in the lives of our customers.”
About DS Healthcare Group
DS Healthcare Group Inc. is a leader in the development of biotechnology for topical therapies. It markets through online channels, specialty retailers, distributors, pharmacies, and salons. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Health Group's flagship brand, visit www.dslaboratories.com or www.facebook.com/DS.Labs
Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov
Investor Relations DS Healthcare Group (888) 404-7770 ext. 3 Investors@DSHealthgroup.com
Source:DS Healthcare Group, Inc.